SLU-PP-332 250MCG

Description

Introducing SLU-PP-332 250mcg from Peptide Therapeutics Institute, an innovative research compound being explored for its impact on mitochondrial biogenesis, fat metabolism, and endurance performance. SLU-PP-332 functions as a small molecule activator of estrogen-related receptor (ERR) transcription factors, specifically targeting pathways associated with cellular energy production and oxidative metabolism. Through this mechanism, experimental models have demonstrated increased PGC-1α expression, enhanced mitochondrial density, and improved fatty acid oxidation. These properties make SLU-PP-332 highly relevant in studies focused on energy homeostasis, athletic endurance, and metabolic adaptation. With its targeted influence on energy-regulating transcription factors, SLU-PP-332 offers researchers a valuable platform for investigating muscle performance, mitochondrial health, and metabolic flexibility. Advance your exploration into cellular energetics and performance optimization with Peptide Therapeutics Institute’s SLU-PP-332 250mcg.

Features

• Novel compound studied for enhancing mitochondrial biogenesis
• Targets ERR-dependent pathways involved in energy metabolism
• Investigated for improving endurance and fatty acid oxidation
• Supports upregulation of PGC-1α and cellular respiration pathways
• Relevant in studies involving athletic performance and metabolic health
• Potential applications in fatigue resistance and energy efficiency research

Why Choose Peptide Therapeutics Institute’s SLU-PP-332 250mcg?

For researchers investigating advanced metabolic and endurance-related pathways, Peptide Therapeutics Institute’s SLU-PP-332 250mcg delivers a high-purity, research-grade formulation with dependable bioactivity. This compound is widely utilized in studies examining transcriptional regulation of mitochondrial function and oxidative energy output, particularly within skeletal muscle models. Its targeted activity on ERR family transcription factors and its influence on mitochondrial performance make it an excellent tool for detailed bioenergetic and metabolic adaptation research. With stable formulation and reliable low-dose activity, SLU-PP-332 supports precise and reproducible outcomes across a broad range of experimental applications. Whether your work focuses on exercise physiology, mitochondrial dysfunction, or cellular energy optimization, Peptide Therapeutics Institute provides the quality and consistency needed for advanced scientific investigation.

Specs

Volume: 250 MCG
Purity: Research Grade

Composition:

• SLU-PP-332

Molecular Weight: Approximately 395.4 Da

Stability: Stable under standard laboratory storage conditions